We also analyzed the correlation of TIMP-1 expression with EFS in treated TPBC (ER+, PR+, HER2 expression) patients of different tumor stages, without finding any significant association with prognosis (p = 0.34) (Figure 2F). The gene discussed is TIMP1; the disease is neoplasm.